NCDM-32B is a potent and selective KDM4 inhibitor, impairing viability and transforming phenotypes of basal breast cancer. References: Ye Q, Holowatyj A, Wu J, Liu H, Zhang L, Suzuki T, Yang ZQ. Genetic alterations of KDM4 subfamily and therapeutic effect of novel demethylase inhibitor in breast cancer. Am J Cancer Res. 2015 Mar 15;5(4):1519-30. eCollection 2015. PubMed PMID: 26101715; PubMed Central PMCID: PMC4473328.

纯度：≥98%

CAS：1239468-48-4